Dawkins and Pratley note that while studies show people with obesity and type 2 diabetes experience significant weight loss on a GLP-1 agonist or dual agonist, people with type 2 diabetes experience slightly less weight loss compared with those with overweight and obesity without type 2 diabetes.1-3 Counseling Tips for RDs Despite the success of these classes of weight management medications, patients can receive anywhere from a little to a lot of information on how to optimize their use since a wide variety of clinicians, from primary care providers to obesity medicine experts, prescribe them
Nslund E, Grybck P, Backman L, Jacobsson H, Holst JJ, Theodorsson E, Hellstrm PM
It has the molecular formula C 14 H 22 CuN 6 O 4 , a molecular weight of 401.9 g/mol, and CAS number 89030-95-5
It is not approved by the FDA for the treatment, prevention, or diagnosis of any disease